HA
HAE icon

Heartland Advisors’s Haemonetics HAE Stock Holding History

Heartland Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15M Buy
200,000
+115,000
+135% +$7.39M 0.67% 44
2026
Q1 		$4.79M Buy
85,000
+10,000
+13% +$651K 0.24% 158
2025
Q4 		$6.01M Sell
75,000
-21,125
-22% -$1.42M 0.32% 126
2025
Q3 		$4.69M Sell
96,125
-60,413
-39% -$3.74M 0.25% 145
2025
Q2 		$11.7M Buy
156,538
+640
+0.4% +$42.4K 0.65% 50
2025
Q1 		$9.91M Buy
155,898
+62,975
+68% +$4.28M 0.57% 72
2024
Q4 		$7.26M Sell
92,923
-48,175
-34% -$3.87M 0.39% 101
2024
Q3 		$11.3M Sell
141,098
-31,603
-18% -$2.55M 0.59% 66
2024
Q2 		$14.3M Sell
172,701
-46,364
-21% -$4.08M 0.8% 48
2024
Q1 		$18.7M Sell
219,065
-2,632
-1% -$207K 0.98% 23
2023
Q4 		$20M Sell
221,697
-34,717
-14% -$3M 1.05% 19
2023
Q3 		$24.4M Sell
256,414
-26,253
-9% -$2.34M 1.37% 9
2023
Q2 		$24.1M Sell
282,667
-45,824
-14% -$3.87M 1.38% 7
2023
Q1 		$27.2M Sell
328,491
-15,014
-4% -$1.22M 1.68% 4
2022
Q4 		$27M Sell
343,505
-68,541
-17% -$5.51M 1.71% 5
2022
Q3 		$30.5M Sell
412,046
-12,000
-3% -$862K 2.28% 1
2022
Q2 		$27.6M Sell
424,046
-15,700
-4% -$929K 1.92% 1
2022
Q1 		$27.8M Buy
439,746
+33,554
+8% +$1.82M 1.72% 3
2021
Q4 		$21.5M Buy
406,192
+51,760
+15% +$3.15M 1.26% 4
2021
Q3 		$25M Buy
354,432
+5,390
+2% +$340K 1.51% 3
2021
Q2 		$23.3M Buy
+349,042
New +$24.7M 1.35% 3
2017
Q4 		– Sell
-165,494
Closed -$7.43M – 203
2017
Q3 		$7.43M Hold
165,494
– – 0.48% 105
2017
Q2 		$6.54M Sell
165,494
-82,180
-33% -$3.38M 0.42% 110
2017
Q1 		$10M Sell
247,674
-103,640
-30% -$4.05M 0.61% 66
2016
Q4 		$14.1M Sell
351,314
-52,626
-13% -$1.98M 0.78% 36
2016
Q3 		$14.6M Buy
403,940
+145,285
+56% +$4.99M 0.84% 31
2016
Q2 		$7.5M Buy
+258,655
New +$7.82M 0.42% 103

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Heartland Advisors's HAE Position: Q2 2026 in Review

Heartland Advisors increased its Haemonetics (HAE) stake by 135% in Q2 2026, buying an estimated $7.39M and bringing the position to 200,000 shares worth $15M. The position accounts for 0.67% of the portfolio, ranked #44.

Heartland Advisors first reported a position in HAE in Q2 2016 and has held it in 27 quarters since. The position peaked at $30.5M in Q3 2022. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Heartland Advisors held 200,000 shares of Haemonetics worth $15M as of Q2 2026.
  • Heartland Advisors bought 115,000 Haemonetics shares in Q2 2026, an estimated $7.39M.
  • Haemonetics made up 0.67% of Heartland Advisors's portfolio in Q2 2026, its #44 holding.
  • Heartland Advisors first reported a position in Haemonetics in Q2 2016 and has held it in 27 quarters since.
  • Heartland Advisors's Haemonetics position peaked at $30.5M in Q3 2022.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Heartland Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.